Lisa Christopher‐Stine
About
Lisa Christopher‐Stine is a scholar working on Epidemiology, Rheumatology and Molecular Biology.
According to data from OpenAlex, Lisa Christopher‐Stine has authored 164 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Epidemiology, 69 papers in Rheumatology and 36 papers in Molecular Biology. Recurrent topics in Lisa Christopher‐Stine's work include Inflammatory Myopathies and Dermatomyositis (142 papers), Eosinophilic Disorders and Syndromes (48 papers) and Muscle Physiology and Disorders (33 papers). Lisa Christopher‐Stine is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (142 papers), Eosinophilic Disorders and Syndromes (48 papers) and Muscle Physiology and Disorders (33 papers). Lisa Christopher‐Stine collaborates with scholars based in United States, Sweden and Spain. Lisa Christopher‐Stine's co-authors include Andrew L. Mammen, Livia Casciola‐Rosen, Sonye K. Danoff, Julie J. Paik, Jemima Albayda, Iago Pinal‐Fernandez, Tae Chung, Andrea M. Corse, Antony Rosen and Thomas E. Lloyd and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.
In The Last Decade
Lisa Christopher‐Stine
156 papers receiving 6.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lisa Christopher‐Stine United States | 40 | 5.5k | 2.6k | 1.5k | 1.4k | 1.2k | 164 | 7.0k | ||
| Lisa G. Rider United States | 50 | 6.1k 1.1× | 3.8k 1.4× | 1.9k 1.3× | 1.6k 1.1× | 711 0.6× | 171 | 8.3k | ||
| Pierre‐Yves Hatron France | 42 | 1.7k 0.3× | 1.7k 0.6× | 866 0.6× | 729 0.5× | 513 0.4× | 142 | 5.7k | ||
| Hector Chinoy United Kingdom | 32 | 2.4k 0.4× | 1.7k 0.6× | 960 0.7× | 726 0.5× | 312 0.3× | 169 | 3.6k | ||
| Jacques‐Eric Gottenberg France | 46 | 719 0.1× | 2.7k 1.0× | 1.7k 1.2× | 1.0k 0.7× | 321 0.3× | 163 | 7.1k | ||
| Franco Franceschini Italy | 37 | 1.2k 0.2× | 2.4k 0.9× | 1.3k 0.9× | 403 0.3× | 265 0.2× | 210 | 4.6k | ||
| Gabriela Riemekasten Germany | 48 | 1.1k 0.2× | 1.9k 0.7× | 2.9k 2.0× | 860 0.6× | 148 0.1× | 237 | 7.1k | ||
| Gordon C. Sharp United States | 39 | 1.6k 0.3× | 2.2k 0.8× | 2.0k 1.4× | 1.3k 0.9× | 191 0.2× | 141 | 6.6k | ||
| Ami A. Shah United States | 40 | 1.3k 0.2× | 730 0.3× | 901 0.6× | 527 0.4× | 126 0.1× | 162 | 5.2k | ||
| Gabriele Valentini Italy | 44 | 1.4k 0.3× | 1.8k 0.7× | 1.6k 1.1× | 798 0.6× | 89 0.1× | 232 | 6.8k | ||
| Chi Chiu Mok China | 55 | 851 0.2× | 6.3k 2.4× | 3.5k 2.4× | 620 0.4× | 613 0.5× | 228 | 8.3k |
Countries citing papers authored by Lisa Christopher‐Stine
Since
Specialization
Citations
This map shows the geographic impact of Lisa Christopher‐Stine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Christopher‐Stine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Christopher‐Stine more than expected).
Fields of papers citing papers by Lisa Christopher‐Stine
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lisa Christopher‐Stine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Christopher‐Stine. The network helps show where Lisa Christopher‐Stine may publish in the future.
Co-authorship network of co-authors of Lisa Christopher‐Stine
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Christopher‐Stine. A scholar is included among the top collaborators of Lisa Christopher‐Stine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Christopher‐Stine. Lisa Christopher‐Stine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Paik, Julie J., Lisa Christopher‐Stine, Mikael Boesen, et al.. (2025). The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review. Frontiers in Immunology. 16. 1455867–1455867.
2.
Saygın, Didem, Dana DiRenzo, Christopher A. Mecoli, et al.. (2024). Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism. 68. 152534–152534.
3.
Saygın, Didem, Victoria P. Werth, Julie J. Paik, et al.. (2024). Response to: Correspondence on ‘Current myositis clinical trials and tribulations’ by Saygin et al. Annals of the Rheumatic Diseases. 83(11). e23–e23.
4.
Christopher‐Stine, Lisa, Hector Chinoy, Namita Goyal, et al.. (2024). The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms. The Journal of Rheumatology. 51(12). 1198–1207.
5.
Saygın, Didem, Helene Alexanderson, Dana DiRenzo, et al.. (2024). The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism. 67. 152476–152476.
6.
Tiniakou, Eleni, et al.. (2024). Comprehensive Enteroviral Serology Links Infection and Anti‐Melanoma Differentiation‐Associated Protein 5 Dermatomyositis. ACR Open Rheumatology. 7(1). e11752–e11752.
7.
Mecoli, Christopher A., David Fiorentino, Jemima Albayda, et al.. (2024). The Relationship Between Anti–Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti‐Sp4 Autoantibodies, and Cancer in Anti–Transcription Intermediary Factor 1γ–Positive Dermatomyositis. ACR Open Rheumatology. 6(12). 912–917.
8.
Albayda, Jemima, Julie J. Paik, Eleni Tiniakou, et al.. (2024). Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies. Lara D. Veeken. 64(4). 2115–2122.
9.
Tiniakou, Eleni, Jemima Albayda, Brittany L. Adler, et al.. (2024). Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases. 84(2). 307–318.
10.
Connolly, Caoilfhionn M, Christopher A. Mecoli, Brittany L. Adler, et al.. (2023). Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series. Lara D. Veeken. 62(8). e237–e239.
11.
Fiorentino, David, Christopher A. Mecoli, Takeru Igusa, et al.. (2023). Association of Anti‐CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti–Transcriptional Intermediary Factor 1γ–Positive Dermatomyositis. Arthritis & Rheumatology. 75(7). 1238–1245.
12.
Mecoli, Christopher A., Brant Chee, Jemima Albayda, et al.. (2023). Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients. Arthritis Care & Research. 75(10). 2142–2150.
13.
Mecoli, Christopher A., Takeru Igusa, Jemima Albayda, et al.. (2022). Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population. Arthritis & Rheumatology. 75(4). 620–629.
14.
DiRenzo, Dana, Didem Saygın, Ingrid de Groot, et al.. (2022). Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism. 58. 152111–152111.
15.
Casal-Domínguez, María, Iago Pinal‐Fernandez, Katherine Pak, et al.. (2021). Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis‐Specific Autoantibodies. Arthritis & Rheumatology. 74(3). 508–517.
16.
Albayda, Jemima, Christopher A. Mecoli, Livia Casciola‐Rosen, et al.. (2021). A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases. ACR Open Rheumatology. 3(5). 287–294.
17.
Pinal‐Fernandez, Iago, Katherine Pak, Albert Gil‐Vila, et al.. (2021). Anti‐Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis. Arthritis & Rheumatology. 74(2). 358–364.
18.
Paik, Julie J., Livia Casciola‐Rosen, Joseph Shin, et al.. (2020). Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients. Arthritis & Rheumatology. 73(5). 858–865.
19.
Pinal‐Fernandez, Iago, Kevin J. Psoter, Julie J. Paik, et al.. (2019). The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease. Respiratory Medicine. 150. 63–65.
20.
Fiorentino, David, Leland W.K. Chung, Lisa Christopher‐Stine, et al.. (2013). Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γ. Arthritis & Rheumatism. 65(11). 2954–2962.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lisa G. Rider Breakdown of academic impact, for papers by Pierre‐Yves Hatron Breakdown of academic impact, for papers by Hector Chinoy Breakdown of academic impact, for papers by Jacques‐Eric Gottenberg Breakdown of academic impact, for papers by Franco Franceschini Breakdown of academic impact, for papers by Gabriela Riemekasten Breakdown of academic impact, for papers by Gordon C. Sharp Breakdown of academic impact, for papers by Ami A. Shah Breakdown of academic impact, for papers by Gabriele Valentini Breakdown of academic impact, for papers by Chi Chiu Mok